Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Nov 15;33(14):2115-2124.
doi: 10.1097/QAD.0000000000002312.

Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease

Affiliations
Comparative Study

Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease

Zheng Wang et al. AIDS. .

Abstract

Background: Prevalence estimates of cognitive impairment in HIV disease vary widely. Here we used multivariate normative comparison (MNC) with identify individuals with impaired cognition, and to compare the results with those using the Frascati and Gisslén criteria.

Methods: The current project used data collected before October 2014 from bisexual/gay men from the Multicenter AIDS Cohort Study. A total of 2904 men (mean age 39.7 years, 52.7% seropositive) had complete data in six cognitive domains at their first neuropsychological evaluation. T-scores were computed for each domain and the MNC was applied to detect impairment among seronegative and seropositive groups.

Results: The MNC classified 6.26% of seronegative men as being impaired using a predetermined 5% false discovery rate. By contrast, the Frascati and the Gisslén criteria identified 24.54 and 11.36% of seronegative men as impaired. For seropositive men, the percentage impairment was 7.45, 25.73, and 11.69%, respectively, by the MNC, Frascati and Gisslén criteria. When we used seronegative men without medical comorbidities as the control group, the MNC, the Frascati and the Gisslén criteria identified 5.05, 27.07, and 4.21% of the seronegative men, and 4.34, 30.95, and 4.48% of the seropositive men as having cognitive impairment. For each method, serostatus was not associated with cognitive impairment.

Conclusion: The MNC controls the false discovery rate and therefore avoids the low specificity that characterizes the Frascati and Gisslén criteria. More research is needed to evaluate the sensitivity of the MNC method in a seropositive population that may be sicker and older than the current study sample and that includes women.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Z.W., S.A.M., Y.C., L.K., A.J.L., E.M., C.A.M., A.R., L.H.R., N.S., E.S., J.T.B. have no conflicts of interest.

Figures

Figure 1:
Figure 1:
Cognitive impairment classification results (seronegative without comorbidities as healthy control reference group)

References

    1. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, et al. Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome. New England Journal of Medicine 1985; 313(24):1493–1497. - PubMed
    1. McArthur JC. Neurologic Manifestations of AIDS. Medicine 1987; 66(6):407–437. - PubMed
    1. Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239(4840):586–592. - PubMed
    1. Jacobson LP, Li R, Phair J, Margolick JB, Rinaldo CR, Detels R, et al. Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease Progression. American Journal of Epidemiology 2002; 155(8):760–770. - PubMed
    1. Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 2016; 86(4):334–340. - PMC - PubMed

Publication types

MeSH terms

Substances